MyFinsight
Home
Blog
About
Back
Income Statement
Calidi Biotherapeutics, Inc. (CLDWW)
Calidi Biotherapeutics, Inc. (CLDWW)
source: myfinsight.com
Net loss
attributable to common...
-$4,160K
(27.21%↑ Y/Y)
Net loss
attributable to controlling...
-$4,160K
(27.21%↑ Y/Y)
Net loss
-$4,160K
(27.79%↑ Y/Y)
Loss before income
taxes
-$4,155K
(27.83%↑ Y/Y)
Income tax provision
$5K
(25.00%↑ Y/Y)
Loss from operations
-$4,150K
(26.73%↑ Y/Y)
Total other income
(expense), net
-$5K
(94.62%↑ Y/Y)
Other income
(expense), net
$31K
(240.91%↑ Y/Y)
Total operating
expense
$4,150K
(-26.73%↓ Y/Y)
Interest
expense-Nonrelated Party
$29K
(0.00%↑ Y/Y)
Interest
expense-Related Party
$6K
(-73.91%↓ Y/Y)
Change in fair value of
other liabilities and...
$1K
(-94.44%↓ Y/Y)
Research and development
$2,558K
(-1.35%↓ Y/Y)
General and
administrative
$1,592K
(-48.16%↓ Y/Y)
Back